High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease

Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).(1) Patients with IBD historically have had low vaccine uptake relative to the general population.(2) However, a recent survey suggested a rate higher than that of the general populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schell, Trevor L., Richard, Luke J., Tippins, Katharine, Russ, Rachel K., Hayney, Mary S., Caldera, Freddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654458/
https://www.ncbi.nlm.nih.gov/pubmed/34896281
http://dx.doi.org/10.1016/j.cgh.2021.12.013
_version_ 1784611866322927616
author Schell, Trevor L.
Richard, Luke J.
Tippins, Katharine
Russ, Rachel K.
Hayney, Mary S.
Caldera, Freddy
author_facet Schell, Trevor L.
Richard, Luke J.
Tippins, Katharine
Russ, Rachel K.
Hayney, Mary S.
Caldera, Freddy
author_sort Schell, Trevor L.
collection PubMed
description Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).(1) Patients with IBD historically have had low vaccine uptake relative to the general population.(2) However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.(3) Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.(4,5)
format Online
Article
Text
id pubmed-8654458
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-86544582021-12-09 High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease Schell, Trevor L. Richard, Luke J. Tippins, Katharine Russ, Rachel K. Hayney, Mary S. Caldera, Freddy Clin Gastroenterol Hepatol Original Article Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).(1) Patients with IBD historically have had low vaccine uptake relative to the general population.(2) However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.(3) Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.(4,5) by the AGA Institute 2022-07 2021-12-09 /pmc/articles/PMC8654458/ /pubmed/34896281 http://dx.doi.org/10.1016/j.cgh.2021.12.013 Text en © 2022 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Schell, Trevor L.
Richard, Luke J.
Tippins, Katharine
Russ, Rachel K.
Hayney, Mary S.
Caldera, Freddy
High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title_full High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title_fullStr High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title_full_unstemmed High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title_short High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
title_sort high but inequitable covid-19 vaccine uptake among patients with inflammatory bowel disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654458/
https://www.ncbi.nlm.nih.gov/pubmed/34896281
http://dx.doi.org/10.1016/j.cgh.2021.12.013
work_keys_str_mv AT schelltrevorl highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease
AT richardlukej highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease
AT tippinskatharine highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease
AT russrachelk highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease
AT hayneymarys highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease
AT calderafreddy highbutinequitablecovid19vaccineuptakeamongpatientswithinflammatoryboweldisease

Ejemplares similares